Synaptogenix Inc (SNPX)

[blu_1]

You mean I'm usually right. I said that NTRP would fall surrounding its uplisting to NASDAQ. It did. I said NTRP would tank on Ph 2b news. It did. I said it would drop to $9. It did, and then some. Sorry I underestimated just how low it would go by a couple dollars, but that is not a lie. I said y'all and Neurotrope are over hyping bryostatin and ignoring its likelihood to cause side effects and adverse events. The results of the 20 mg group for SIB were only half the improvement of Aricept. Full side effects were not even released. Just a mention of diarrhea, which is a BIG deal in elderly compromised people whom are susceptible to dehydration. A big knock on donepezil is that it often raunches the GI tracts of users. Same seems to be true for bryostatin in Alzheimers patients.